Skip to main content
. 2010 Feb 15;15(2):122–129. doi: 10.1634/theoncologist.2009-0240

Figure 1.

Figure 1.

Study design, populations, randomization, and assessment of events.

Abbreviations: HER-2, human epidermal growth factor receptor 2; ITT, intent to treat; MBC, metastatic breast cancer; PD, progressive disease; PFS, progression-free survival; po, orally.